期刊文献+

91例无症状肺癌的临床特点分析 被引量:2

Clinical features of asymptomatic pulmonary carcinoma:An analysis of 91 patients
下载PDF
导出
摘要 目的分析无症状肺癌患者的临床特点,评价体检对肺癌早期诊断的临床意义,探讨早期诊断肺癌的策略。方法对近6年在本院发现的91例无症状肺癌患者的临床资料进行回顾性分析。结果无症状肺癌中男性好发,男女比例2∶1,平均年龄(56.63±0.67)岁,在老年与非老年中的分布相近;腺癌最多见,以周围型为主,好发于右肺上叶;主要确诊方法首先是手术,其次是支气管镜检查;非小细胞肺癌早期48例(60.0%)多于晚期的32例(40.0%);12例发生2个部位以上的转移。结论无症状肺癌起病隐匿,被发现时并非完全是早期,应提倡定期体检和早期及时手术。 Objective To analyze the clinical features of patients with asymptomatic pulmonary carcinoma,evaluate the clinical significance of health check-up in early discovery of pulmonary carcinoma and investigate the way to discover the pulmonary carcinoma in its early stages.Methods The clinical data of 91 cases with asymptomatic pulmonary carcinoma in recent 6 years were retrospectively analyzed.Results The majority was men in asymptomatic lung cancer,and male/female ratio was 2:1.Average age was(56.63±0.67) years.The distribution in the elderly and non-elderly was similar. Adenocarcinoma with peripheral type of lung cancer was most common.Furthermore,the diseased were mainly located in superior lobe of right lung.The major diagnosis method was surgery while the secondary method was bronchoscopy.There were 48(60.0%) non-small cell lung cancer patients in early stages and 32(40.0%) in advanced stages.There was a significant difference between two groups.Twelve cases had more than two metastatic sites.Conclusion The outbreak of asymptomatic pulmonary carcinoma is insidious of its onset.It will not be in its early stage once it is confirmed.Accordingly,regular health check-up and timely surgical treatment should be recommended.
出处 《实用临床医药杂志》 CAS 2012年第1期102-104,共3页 Journal of Clinical Medicine in Practice
基金 2011年内蒙古自然科学基金 课题编号:2011MS1122
关键词 无症状肺癌 体检 临床特点 asymptomatic pulmonary carcinoma health check-up clinical features
  • 相关文献

参考文献7

二级参考文献30

  • 1白春学,张新.应重视肺癌的基础研究[J].中华医学杂志,2006,86(37):2593-2595. 被引量:3
  • 2Jenaal A, Murray T, Ward E, et al. Cancer Statistics 2005[J]. CA CancerClin, 2005, 55 (1): 10-30.
  • 3Mountain C. Revisions in the International Staging System for StagingLungCancer[J].Chest, 1997, 111 (6): 1710-1717.
  • 4American College of Chest Physicians. Health and Science Policy Committee.Diaguosis and management of lung cancer: ACCP evidence- based guidelines. American College of Chest Physicians [J]. Chest, 2003, 123: S1-337.
  • 5Aberle D, Brown K. Eung cancer screening with CT[J]. Clin Chest Med, 2008, 29 (1): 1-14.
  • 6BlackWC. Overdiagnosis: an underrecognized cause of confusion and harm in cancer screening [J]. J Natl Cancer Inst, 2000, 92: 1280-1282.
  • 7Goldin JG, Brown MS, Petkovska I. Computer-aided diagnosis in lung nodule assessment [J]. Thorae Imaging, 2008, 23 (2): 97- 104.
  • 8Lillington GA.Solitary pulmonary nodules: new wine in old bottles [J]. Pulm Med, 2001, 7: 242-246.
  • 9Henschke CI, McCauley DI, Yankelevitz DF, et al. Early Lung Cancer Action Project: overall design and findings from baseline screening[J]. Lancet, 1999, 354 (9173): 99-105.
  • 10Henschke CI, Naidich DP, Yankelevitz DF, et al. Early lung-cancer action project: initial findings on repeat screenings [J]. Cancer, 2001, 92 (1): 153-159.

共引文献22

同被引文献19

  • 1Izumo T,Sasada S,Chavez C,et al.The value of chest tomosyn-thesis in locating a ground glass nodule(GGN)during endo-bronchial ultrasonography with a guide sheath:a case report[J].Thorac Dis,2013,5:e75-77.
  • 2Zarogoulidis P,Cheva A,Zarampouka K,et al.Tocopherols andtocotrienols as anticancer treatment for lung cancer:future nutri-tion[J].Thorac Dis,2013,5:349-352.
  • 3Karamustafaoglu YA,Yornk Y,Yanik F,et al.Sentinel lymphnode mapping in patients with operable non-small cell lung canc-er[J].Thorac Dis,2013,5:317-320.
  • 4Arconett CN,Zhou B,Rieger ME,et al.Integrated transcriptomicand epigenomic analysis of primary human lung epithelial celldifferentiation[J].PLoS Genet,2013,9:el003513.
  • 5Salati M,Refai M,Pompili C,et al.Major morbidity after lung re-section:a comparison between the european society of thoracicsurgeons database system and the thoracic morbidity and mortali-ty system[J].Thorac Dis,2013,5:217-222.
  • 6Matsuura T,Miyamoto N,Shimizu S,et al.Integration of a real-time tumor monitoring system into gated proton spot-scanningbeam therapy:an initial phantom study using patient tumor traj-ectory data[J].Med Phys,2013,40:721-729.
  • 7Christian Rolfo,Luis E Raez,Giuseppe Bronte,Edgardo S Santos,Kostantinos Papadimitriou,Lucio Buffoni,Jan P van Meerbeeck,Antonio Russo.BIBF 1120/ nintedanib : a new triple angiokinase inhibitor-directed therapy in patients with non-small cell lung cancer[J]. Expert Opinion on Investigational Drugs . 2013 (8)
  • 8Florence Guida,Sophie Paget-Bailly,Farida Lamkarkach,Oumar Gaye,Stéphane Ducamp,Gwenn Menvielle,Alexandra Papadopoulos,Mireille Matrat,Jo?lle Févotte,Sylvie Cénée,Diane Cyr,Annie Schmaus,Matthieu Carton,Loredana Rado?,Bénédicte Lap?tre-Ledoux,Florence Molinié,Danièle Luce,Isabelle Stücker.Risk of Lung Cancer Associated With Occupational Exposure to Mineral Wools: Updating Knowledge From a French Population-Based Case–Control Study, the ICARE Study[J]. Journal of Occupational and Environmental Medicine . 2013 (7)
  • 9J G H Sutherland,K M Furutani,R M Thomson.A Monte Carlo investigation of lung brachytherapy treatment planning[J]. Physics in Medicine and Biology . 2013 (14)
  • 10Tulek B,Koylu H,Kanat F,et al.Serum C-reactive protein and procalcitonin levels in non-small cell lung cancer patients. Contemp Oncol (Pozn) . 2013

引证文献2

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部